Verastem Inc

NASDAQ:VSTM   3:50:53 PM EDT
2.69
0.00 (-0.19%)
Other Pre-Announcement

Verastem Q4 Posts Adjusted Loss Per Share $0.09

Published: 03/18/2021 21:20 GMT
Verastem Inc (VSTM) - Verastem Oncology Reports Fourth Quarter and Full Year 2020 Financial Results, Clinical Updates and Guidance for Key Milestones in 2021 and 1h 2022.
Q4 Adjusted Non-GAAP Loss per Share $0.09.
Q4 Loss per Share $0.12.
Q4 Revenue $500,000 Versus $3.6 Million.
Strong Balance Sheet With Cash, Cash Equivalents and Investments Totaling $147.2 Million, Expected to Have Cash Runway Until at Least 2024.